137 related articles for article (PubMed ID: 47335)
1. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
Sizemore GW; Hpeath H; Larson JM
J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
[TBL] [Abstract][Full Text] [Related]
2. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
3. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
Myhre L; Gautvik KM
Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical heterogeneity of calcitonin in plasma.
Deftos LJ; Roos BA; Bronzert D; Parthemore JG
J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical and biological characterization of calcitonin originating from transplanted medullary thyroid carcinoma in rats.
Myhre L; Ekeland A; Gautvik KM
Acta Endocrinol (Copenh); 1982 Mar; 99(3):397-403. PubMed ID: 7072448
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma.
Heath H; Sizemore GW
J Lab Clin Med; 1979 Mar; 93(3):390-401. PubMed ID: 429850
[No Abstract] [Full Text] [Related]
12. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
13. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
Birnbaum RS; Muszynski M; Roos BA
Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
[TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
[TBL] [Abstract][Full Text] [Related]
15. A new bioactive form of human calcitonin.
Tobler PH; Dambacher MA; Born W; Heitz PU; Maier R; Fischer JA
Cancer Res; 1983 Aug; 43(8):3793-9. PubMed ID: 6861143
[TBL] [Abstract][Full Text] [Related]
16. Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies.
Zeytinoglu FN; Gagel RF; DeLellis RA; Wolfe HJ; Tashjian AH; Hammer RA; Leeman SE
Lab Invest; 1983 Oct; 49(4):453-9. PubMed ID: 6353060
[TBL] [Abstract][Full Text] [Related]
17. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
[TBL] [Abstract][Full Text] [Related]
18. Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage.
Tiegs RD; Body JJ; Barta JM; Heath H
J Bone Miner Res; 1986 Aug; 1(4):339-49. PubMed ID: 3503547
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.
Tobler PH; Tschopp FA; Dambacher MA; Born W; Fischer JA
J Clin Endocrinol Metab; 1983 Oct; 57(4):749-54. PubMed ID: 6885964
[TBL] [Abstract][Full Text] [Related]
20. Immunoextracted calcitonin from human seminal plasma constitutes different forms.
Bucht E; Arver S; Sjöberg HE
Acta Physiol Scand; 1986 Feb; 126(2):289-93. PubMed ID: 3705987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
